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in 2005-2010. The etiology and type of valvular heart disease have been clas-
sified on the basis of surgicalreports.
Results: The distribution of etiologies differed significantly different
between the two periods (p<0.0001). We noted a decrease in rheumatic
valvular disease with 1,558 cases (95%) in the first period and 894 cases
(81%) in the second period. Consistantly, we observed an increase in
degenerative etiology from 1.6% to 16%, and particularly fibroelastic
degeneration: 20 (1.6%) and 146 (13.3%) cases. The mechanism of val-
vular disease (mitral regurgitation versus mixed mitral valve disease and
mitral stenosis) differed significantly (p<0.0001) for both periods. With
regard to mitral regurgitation cases only, degenerative etiologies increased
from 11.4% to 38.5% of cases between the two periods (p<0.0001).
Patients had a mean age of 36.3 years with a female predominance (two
thirds of patients), especially in rheumatic etiologies. Age (p<0.0001) and
the proportion of urban residents (p=0.04) was increased in degenerative
causes.
Conclusion: The study shows the emergence of degenerative valvular
disease in Vietnam and a decrease in rheumatic valvular heart disease, which
nevertheless remains the most common etiology. 
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The mitral valve prolapse (MVP) is a common cardiac disorder which
affects 2-4% of the population and remains one of the most frequent
indications for valvular surgery. The familial nature of MVP has been
proposed for many years and so far, FLNA remains the only identified
gene. 
Recently, it has been shown that FLNA mutations deregulate the RhoA/
Rac1 GTPases balance and provided evidences for a role of the Rac1 specific
GTPase activating protein, FilGAP, in this network. FilGAP is a recognized
FlnA-binding RhoGTPase-activating protein.
Giving the tight interactions of FlnA and FilGAP, we first tested, using a
candidate gene approach, the hypothesis that FilGAP, encoded by ARHGAP24,
could be involved in MVP.
We have sequenced ARHGAP24 in 95 MVP operated patients and identi-
fied 3 rare missense mutations in highly conserve residues (FilGAP p.R95Q;
p.P417H and p.T481M). One mutation was novel and the 2 others present a
minor allele frequency lower than 0.1% in EVS. Moreover, p.T481M co-seg-
regates with the pathology in a family with 3 affected patients.
We then investigated the impact of these mutations in HEK293 cells. The
role of FilGAP is to decrease Rac1 activity and thus to regulate cell processes
involved in actin cytoskeleton properties as adhesion, protrusion and intracel-
lular dynamics.
From pull-down assays, we have shown that FilGAP mutations alter Rac1
GTPase activity and significantly decrease the FilGAP interaction with the
active form of Rac1 (p<0.01). We have also shown, using the XCELLigence
system, that cell adhesion and spreading was significantly increased with
mutated FilGAP (p<0.01). Our results indicate that ARHGAP24 variants are
loss-function mutations.
Moreover, we demonstrate that FilGAP mutations alter the downstream
signaling pathway by two different mechanisms. FilGAP p.P417H and
p.T481M decrease the interaction with FlnA while p.R95Q impacts the plasma
membrane anchorage. 
This work reinforces the involvement of GTPases pathway in MVP patho-
genesis.
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Background: In stress echo Doppler cardiac of mitral stenosis (MS), the
cut point of the mean mitral gradient (MMG) at the peak of the effort pro-
posed by the American Recommendations for mitral dilation is 15mmHg.
However, this value is questioned in the literature
Objective: In stress echo Doppler, determine the peak effort cutoff value
of the MMG prediction of the occurrence of dyspnea justifying percutaneous
mitral dilation in patients with MS
Methodology: Prospective descriptive study conducted in the Cardiology
Department Hospital Beni Messous (Algiers) between March 2008 and
December 2010. Have been included patients with mitral area ≤2 cm², func-
tional class I to III NYHA and systolic pulmonary artery pressure ≤60mm Hg
at rest. Dyspnea was sought to stress test on a treadmill (30W/3min). Dyspneic
patients are those who have stopped the examination for a load ≤90W due to
the occurrence of severe dyspnea. The stress echo Doppler was performed on
table echocardiography (30W/3min). The MMG was measured at baseline and
at the end of each level to the peak of the effort 
Results: Three hundred patients were included (mean age 42.3±1.3 years,
81.3% female). At the end of the stress test, 182 had dyspnea (60.6%). Areas
under the curve of the MMG at peak stress is equal to 0.80, 95% confidence
interval= 0.75-0.85 (p<10-3). In predicting dyspnea justifying percutaneous
mitral dilation, the optimal cutoff value of the MMG corresponds to 33.5
mmHg: sensitivity=0.55, specificity=0.96, positive likelihood=13.21, positive
predictive value (PPV) =95%, positive predictive error (PPE) =5%, Informa-
tive Expected Capacity (IEC) =109. However, the diagnostic quality of the
MMG at maximum effort with the cut point of 15 mmHg proposed by the
American Recommendations is low: sensitivity=0.98, specificity=0.008, posi-
tive likelihood=0.98, PPV=60.0%, PPE=40.0%, IEC= 0.25.
Conclusion: In this study, the optimal cutoff value of the MMG predictive
peak effort dyspnea justifying the percutaneous mitral dilation is 33.5 mmHg,
above the cut point proposed by American Guidelines. 
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Assessment of paravalvular aortic regurgitation (AR) after transcatheter
aortic valve implantation (TAVI) using Edwards SAPIEN XT valve remains
challenging using transthoracic echocardiography (TTE) or angiography. Car-
diac magnetic resonance imaging (c-MRI) has a low intraobserver and
interobserver variability in the assessment of regurgitant volumes and might
be more reliable to assess AR post-TAVI. We therefore aimed to evaluate the
value of c-MRI to assess paravalvular AR after TAVI. Between February
2012 and March 2013, 132 consecutive patients underwent successful TAVI
using exclusively Edwards SAPIEN XT prosthesis. AR was evaluated by c-
MRI, TTE and angiography in 45 patients (27 women, mean age 84.1±7.1
years). Angiography was performed immediately after TAVI whereas TTE
and c-MRI were performed one month after implantation. At baseline c-MRI,
the mean aortic regurgitant fraction (ARF) was 21.3±12.5%. A significant AR
(> grade II) was present in 24 (56%) patients using c-MRI (30< ARF>50 Y%)
whereas it was only observed in 18 (40%) and 12 (27%) patients using TTE
and angiography, respectively. Interestingly, there was a poor correlation
between c-MRI and TTE (r=0.16, p=0.28) and between c-MRI and angio-
graphy (r=0.30, p=0.06). In contrast, there was a good correlation between
TTE and angiography (r=0.6, p<0.001). TTE underestimated AR by one
degree in 9 patients, and by two degrees in 6 patients as compared to c-MRI.
The results of our study suggest that TTE and angiography may underestimate
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the severity of AR after TAVI as compared to c-MRI. Furthermore, there is a
poor correlation between c-MRI and TTE or angiography. Further studies are
mandatory to confirm our results in a larger population. 
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Background: Previous studies suggested that a low flow defined as an
indexed stroke volume (SVi) < 35 ml/m2 may be an important determinant of
outcome in patients with severe aortic stenosis (AS). However, its quantifica-
tion using echocardiography may be subject to error measurement. The aim of
this study is to determine the impact of low SVi determined during cardiac
catheterization on long-term survivalamong patients with severe aortic ste-
nosis and preserved LV ejection fraction.
Methods and Results: Between 2000 and 2010, 768 patients with pre-
served LVEF (>50%) and severe AS (valve area ≤1cm²) without other val-
vular heart disease underwent cardiac catheterization. SVi was derived from
catheterization data.
Mean age was 74±8 years, 42% were female, 46% had coronary artery dis-
ease and mean LVEF was 72±10%. Overall, low SVi was found in 27%
(n=...) of AS patients.
As compared to patients with normal SVi, those with decreased SVi were sig-
nificantly older (p<0.0001) and had more frequently atrial fibrillation (p<0.0001)
in addition, they had lower LVEF (p=0.04),; aortic valve area (p<0.0001), mean
pressure gradient (p= 0.001), systemic arterial compliance (p<0.0001) and higher-
systemic vascular and pulmonary resistances (p<0.0001). 
Ten-year survival was significantly reduced in patients with lower SVi
as compared to those with normal SVi (41±5% vs. 63±3%; p=0.0007,
Figure). After adjustment for all other risk factors, SVi was independently
associated with long-term survival (hazard ratio =0.97, 95%CI: 0.95-0.99;
p=0.01). 
Conclusion: Low SVi measured invasively is frequent in patients with
severe AS and preserved LVEF and is a powerful and independent predictor
of survival. SVi should be systematically measured and used as an additional
parameter for risk stratification of patients with severe AS. 
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Objectives: To evaluate feasibility, safety and advantage of underexpan-
sion of Edwards SAPIEN XT prosthesis during transcatheter aortic valve
implantation (TAVI).
Methods: We retrospectively analyzed 157 transfemoral TAVI proce-
dures performed between October 2012 and December 2013 in the Univer-
sity Hospital of Rouen. Thirty-six (22.9%) patients had intentional
underexpansion of the EDWARDS SAPIEN XT prosthesis since more than
20% area oversizing was anticipated with Computed tomography (CT)
assessment of aortic annulus. Underexpansion of Edwards SAPIEN XT
prosthesis was performed by reducing the volume of fluid within the valve
deployment balloon. The Primary endpoint was aortic regurgitation (AR)
at the end of the procedure. 
Results: Mean age was 83.4±5.8 years and the mean logistic EuroSCORE
of 15.4±9.6%. The initial fluid volume used for valve deployment was
90.1±3.1% of the theorical total volume (TTV) without significant difference
among the 3 sizes of prostheses (90.2±4.1%, 89.5±2.6%, and 84.8±3.2% for
23, 26, and 29-mm valves, respectively). AR immediately after the first infla-
tion was grade ≤I in 20 (55.6%) pts, grade II in 9 (25%) pts, and grade III in
7 (19.4%) pts. Stent diameter measured immediately after first inflation repre-
sented 94.2±4.1% of the prosthesis theorical diameter. Post-dilatation was
deemed necessary in 14 cases (39.4%). At the end of the procedure, AR was
< grade I in 34 (94.4%) patients and grade II in the 2 remaining patients. After
post-dilatation, one patient presenting with fatal aortic annulus rupture. Other
procedures were safe without stroke, myocardial infarction, or prosthesis
migration. 
Conclusion: Our study suggest that underexpansion of Edwards SAPIEN-
XT prosthesis is feasible during transfemoral TAVI procedures when more
than 20% area oversizing is anticipated by CT. However, post-dilatation is
mandatory in about 40% of cases to reduce significant residual aortic regurgi-
tation but can be complicated by aortic annulus rupture 
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Aim: Transcatheter aortic valve implantation (TAVI) is an alternative to
surgical aortic valve replacement for high-risk patients. The relative event
rates following TAVI have not yet been well described and seem to differ
between genders. We sought to determine gender imbalances in TAVI patients
with regard to baseline presentation, management, and prognosis.
Methods and results: A total of 3,972 patients underwent TAVI and were
prospectively included in the FRANCE 2 registry.
Women (n=1967) presented with older age and lower rates of coronary
artery disease, chronic obstructive pulmonary disease, renal failure, and
arrhythmia, though higher prevalence of hypertension and congestive heart
failure (43.7% vs. 39.7%; p=0.010). EuroSCORE was similar between gen-
ders. Women presented with smaller aortic annulus and were implanted with
smaller bioprostheses.
At 1 month, mortality rates were similar between genders. Multivariate
analysis revealed the following independent predictors for 1-month all-cause
mortality: female gender; New York Heart Association (NYHA) Class III or
IV; transapical approach; moderate to severe postprocedural aortic regurgita-
tion. We observed a specific interaction between gender and EuroSCORE,
confirming EuroSCORE as less capable to discriminate women in order to
establish 1-month mortality. Women presented with lower 1-year mortality
rates than men (19.3% vs. 23.7%; p=0.021). Female gender was an indepen-
dent predictor of 1-year survival (HR: 0.71, 95% CI: [0.57-0.88]).
Conclusion: Men and women exhibited several differing baseline charac-
teristics, as well as procedural and clinical outcomes. Notably, Euroscore
proved inconvenient for 1-month survival prediction in women. Women also
presented with an 18.5% decrease in 1-year all-cause mortality compared to
men. 
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